IATI-Biomed 2015 : le succès de la filière israélienne des sciences de la vie
[:fr]Le secteur a reçu plus de 800 millions de dollars d’investissements en capital-risque en 2014. Si le dynamisme des start-up israéliennes dans la high-tech est bien connu, c’est loin d’être le seul secteur à susciter la convoitise. La filière des sciences de la vie fait elle aussi preuve d’une belle vitalité, révèle un rapport publié à l’occasion du Salon IATI Biomed, qui s’est tenu la semaine dernière à Tel-Aviv.
Composée de près de 1 400 sociétés spécialisées dans l’instrumentation médicale (à 53 %), la biopharma (23 %) ou les solutions connectées (20 %), cette industrie a reçu un niveau de financement record au cours de l’année écoulée. Après l’avoir longtemps boudé, le capital-risque a investi plus de 800 millions de dollars en 2014 dans le « biomed » israélien, souligne le centre de recherche IVC. Un chiffre en hausse de 55 % par rapport à 2013 et un bond en avant spectaculaire par rapport à une moyenne annuelle de 371 millions sur la période 2005-2011…
Article complet sur Les Echos [:en]
The 14th annual IATI-Biomed 2015, the premier international biomed conference in Israel, took place between May 12-14, 2015, at the Trade Fairs and Convention Center in Tel Aviv, Israel. “In addition to showcasing the Israeli spirit of entrepreneurship and innovation.” IATI life sciences report is on line.
For the 14th consecutive year, IATI-Biomed was the largest and leading meeting place for healthcare professionals from Israel with international colleagues and partners. As such, this world-class event presented an opportunity for global participants to experience Israel’s life science innovation and vibrant biomedical industry at its best.
Previous successful conferences hosted over 6,000 industry players, scientists and engineers including more than 1,000 attendees from over 45 countries that participated in over 4,500 one-on-one meetings. As in previous years, hundreds of Israeli life science companies presented and exhibited their products, services and technologies allowing for hands-on experience.
Ruthi Alon, IATI-Biomed Co-Chairperson and General Partner Pitango Venture Capital, said, “Biomed 2015 offered an attractive networking venue and business opportunity for players across the biomed industry to create new partnerships and collaborations. This is the biggest and most established annual meeting of the Israeli life science industry, and as such attracts senior representatives from global companies that search for innovation and ground breaking technologies.”
Dr. Benny Zeevi, IATI-Biomed Co-Chairperson, Co-Chairman of the IATI and Managing General Partner DFJ Tel Aviv Venture Partners, added, “In addition to showcasing the Israeli spirit of entrepreneurship and innovation, we discussed the hottest areas in life sciences today, ranging from digital health to new business models, and examined future trends and crucial components for success.”[:]
